المؤلفون: Giverhaug, Trude, Raknes, Guttorm

المصدر: Norsk Farmaceutisk Tidsskrift. 127(6):28

المؤلفون: Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel

المصدر: ISSN: 0269-9370 ; AIDS, vol. 31, no. 13 (2017) p. 1853-1858.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Adolescent, Adult, Aged, 80 and over, Anti-HIV Agents/administration & dosage/adverse effects, Drug-Related Side Effects and Adverse Reactions/epidemiology, Female, HIV Infections/drug therapy, Heterocyclic Compounds, 3-Ring/administration & dosage/adverse effects, Humans, Male, Mental Disorders/chemically induced/epidemiology, Middle Aged, Prospective Studies, Raltegravir Potassium/administration & dosage/adverse effects, Switzerland, Withholding Treatment, Young Adult

Relation: info:eu-repo/semantics/altIdentifier/pmid/28692533; https://archive-ouverte.unige.ch/unige:112378; unige:112378

الاتاحة: https://archive-ouverte.unige.ch/unige:112378

المؤلفون: John, Gregor Raphaël, Ollo, Diana, Meyer, Patrick, Samer, Caroline Flora, Calmy, Alexandra

المصدر: ISSN: 0269-9370 ; AIDS, vol. 27, no. 17 (2013) p. 2827-2828.

مصطلحات موضوعية: info:eu-repo/classification/ddc/610/370, info:eu-repo/classification/ddc/616, Anti-HIV Agents/administration & dosage/adverse effects, Anti-Inflammatory Agents/administration & dosage/adverse effects, Cushing Syndrome/chemically induced, Humans, Iatrogenic Disease, Male, Middle Aged, Pulmonary Embolism/chemically induced, Ritonavir/administration & dosage/adverse effects, Triamcinolone/administration & dosage/adverse effects

Relation: info:eu-repo/semantics/altIdentifier/pmid/24384635; https://archive-ouverte.unige.ch/unige:90406; unige:90406

الاتاحة: https://archive-ouverte.unige.ch/unige:90406

المؤلفون: Anonymous

المصدر: Information från Läkemedelsverket. 19(3):76

المؤلفون: Eliasson, E

المصدر: Läkartidningen. 105(22):1644

المؤلفون: Andersson, E

المصدر: Sjukhusfarmaci. (1):40

المؤلفون: Hornstrup, M K, Kvinesdal, B B, Pedersen, C

المصدر: Ugeskrift for Laeger. 164(47):5491

المؤلفون: Ulvestad, E, Åsjö, B

المصدر: Tidsskrift for Den Norske Laegeforening. 121(29):3421

المؤلفون: Fontas, E., van Leth, F., Sabin, C. A., Friis-Moller, N., Rickenbach, M., d'Arminio Monforte, A., Kirk, O., Dupon, M., Morfeldt, L., Mateu, S., Petoumenos, K., El-Sadr, W., de Wit, S., Lundgren, J. D., Pradier, C., Reiss, P.

المصدر: Journal of Infectious Diseases, vol. 189, no. 6, pp. 1056-74

مصطلحات موضوعية: Adult Anti-HIV Agents/administration & dosage/*adverse effects Cholesterol/blood Coronary Disease/etiology Cross-Sectional Studies Drug Therapy, Combination Female HIV Infections/blood/*drug therapy Humans Indinavir/adverse effects Lipids/*blood Logistic Models Male Prospective Studies Ritonavir/adverse effects Saquinavir/adverse effects Triglycerides/blood

وصف الملف: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/14999610; info:eu-repo/semantics/altIdentifier/pissn/0022-1899; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5F4C94BAD5210; https://serval.unil.ch/notice/serval:BIB_5F4C94BAD521; https://serval.unil.ch/resource/serval:BIB_5F4C94BAD521.P001/REF.pdf

الاتاحة: https://serval.unil.ch/notice/serval:BIB_5F4C94BAD521
https://doi.org/10.1086/381783
https://serval.unil.ch/resource/serval:BIB_5F4C94BAD521.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5F4C94BAD5210

المؤلفون: Bredberg-Råden, U

المصدر: Läkemedelsvärlden. 104(9):23

المؤلفون: Nathan Ford, Nicholas I. Paton, María Eugenia Socías, Evan Popoff, Keith Chan, Meg Doherty, Steve Kanters, Dieter Ayers, Matthew O. Wiens, Edward J Mills, Alexandra Calmy, Marco Vitoria, David A. Cooper, Sabin Nsanzimana

المصدر: The Lancet HIV, Vol. 4, No 10 (2017) pp. e433-e441

مصطلحات موضوعية: Male, 0301 basic medicine, Epidemiology, Network Meta-Analysis, HIV Infections, Pharmacology, Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use, Lopinavir, 0302 clinical medicine, immune system diseases, Prospective Studies, 030212 general & internal medicine, ddc:616, Reverse-transcriptase inhibitor, virus diseases, Infectious Diseases, HIV-1/drug effects, Raltegravir Potassium/administration & dosage/adverse effects/therapeutic use, Acquired Immunodeficiency Syndrome/drug therapy, Ritonavir/administration & dosage/adverse effects/therapeutic use, Meta-analysis, Reverse Transcriptase Inhibitors, Female, Lopinavir/administration & dosage/adverse effects/therapeutic use, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Anti-HIV Agents, HIV Protease Inhibitors/administration & dosage/adverse effects/therapeutic use, 030106 microbiology, Immunology, HIV Infections/drug therapy, 03 medical and health sciences, Raltegravir Potassium, Virology, Internal medicine, medicine, Humans, Adverse effect, Darunavir, Retrospective Studies, Acquired Immunodeficiency Syndrome, Ritonavir, business.industry, Retrospective cohort study, HIV Protease Inhibitors, Raltegravir, Regimen, HIV-1, Reverse Transcriptase Inhibitors/administration & dosage/adverse effects/therapeutic use, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5606894d826bac37fb664fc6646ba841
https://doi.org/10.1016/s2352-3018(17)30109-1

المؤلفون: Meldgaard Madsen, K, Gerstoft, J, Kvinesdal, B B, Nielsen, H I, Möller, A, Pedersen, C, Obel, N

المصدر: Ugeskrift for Laeger. 161(48):6619

المؤلفون: Martin, Charlotte, Payen, Marie-Christine, De Wit, Stéphane

المصدر: International journal of STD & AIDS, 29 (10

مصطلحات موضوعية: Pathologie maladies infectieuses, Santé publique, Dermatologie, Pharmacologie, Anti-HIV Agents -- administration & dosage -- adverse effects, Antiretroviral Therapy, Highly Active, Drug Hypersensitivity Syndrome -- diagnosis, Drug Interactions, Eosinophilia -- chemically induced, Exanthema -- chemically induced, Fatal Outcome, HIV Integrase Inhibitors -- administration & dosage -- adverse effects, Heterocyclic Compounds, 3-Ring -- administration & dosage -- adverse effects, Humans, Male, Middle Aged, Oxazines, Piperazines, Pyridones, dolutegravir, human immunodeficiency virus, toxicity

وصف الملف: No full-text files

Relation: uri/info:doi/10.1177/0956462418764973; uri/info:pmid/29621952; uri/info:scp/85045049909; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/287665

الاتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/287665

المؤلفون: Brenda Homony, Claudine Duvivier, I Neves, Christine Katlama, Gordon Crofoot, Natalia Zakharova, Stefan Esser, Hedy Teppler, Xia Xu, Randi Y. Leavitt, Adriano Lazzarin, CR Mejia, M Mustafa, Olga Aleksandrovna Tsybakova, James H McMahon, Brian Conway, Juan Carlos Rondon, Faiza Ajana, TS Chow, M Oyanguren, EM Rojas, Jean-Michel Molina, A Avihingsanon, Carlos Perez, Koldo Aguirrebengoa, Karen T. Tashima, M Wolff, Yazdan Yazdanpanah, Eugenia Negredo, R Serrao, Richard James Moore, Carmen D. Zorrilla, Winai Ratanasuwan, C Echiverri, L Panther, Joel E. Gallant, Andri Rauch, HH Lin, Bernard Vandercam, Anthony John Scarsella, L Hercilla, A. Antinori, Pedro Cahn, Albrecht Stoehr, DE Sweet, Mariette E. Botes, Johannes R. Bogner, Hans Jaeger, Soumi Gupta, Olaf Degen, Nathan Clumeck, H. Hartl, PJ Ruane, Ckc Lee, Juergen K. Rockstroh, Richard Kaplan, N Roth, MF Lasso, Rassool, Gatell Jm, Markus Bickel, Nelson, M Moutschen, V Sotnikov, R Kaplan, Amanda Clarke, WH Sheng, Anchalee Avihingsanon, Doug Ward, L Vanderkerckhove, Daniel S Berger, Sasisopin Kiertiburanakul, Ghr Smith, Sandy L. Rawlins, Mohammed Rassool, A d'Arminio Monforte, Paul E. Sax, Margaret A. Johnson, F. Maggiolo, Fernando Maltez, Ramirez, Evgeny Voronin, Eyal Shahar, S Henn, Cheryl McDonald, A Ustianowski, MT Bloch, E Arathoon, Peter Sklar, LD Gonzalez, Enrique Ortega, Louis Sloan, Amneris E. Luque, Isabelle Poizot-Martin, M. H. Losso, Giuliano Rizzardini, Debbie Hagins, Lilly East, Andrea Gori, Matthias Cavassini, Princy Kumar, Isabel Cassetti, G. Di Perri, Benedetto Maurizio Celesia, Evelyn Rojas, S Ferret, Jerry L. Cade, KM Mullane, CB Hsiao, Dane Turner, Eugénio Teófilo, Bach-Yen Nguyen, Craig A. Dietz, Anthony Rodgers, Elena Orlova-Morozova, Z. Sthoeger, Jean-Guy Baril, Hila Elinav, I Khaertynova, JG Saraiva da Cunha, Carl J. Fichtenbaum, G Faetkanheuer, Peter Ruane, HC Tsai, R Iskandar Shah Raja Azwa, Lerato Mohapi, Firaya Nagimova, Keikawus Arastéh, J. Durant, JD Velez, Jacques Reynes, ST Lewis, Saag, Otto Sussmann, P. Cahn, D Changpradub, Mark Bloch, RM Novak, W Ratanasuwan, Kathleen Squires, Fiona Smaill, Larissa Wenning, Jose R. Arribas, Edwin DeJesus, Don Smith, JO Morales, A. Yakovlev, Sharon Walmsley, Carolina Eugenia Chahin, I Levy, Alexandra Calmy, David James Prelutsky, David M. Asmuth, Linos Vandekerckhove, J Troya, Antonio Antela, Alan Winston, Lizette Santiago, Juan Berenguer, Marcel Stoeckle, RA Castillo, Anita Rachlis

المساهمون: Service de maladies infectieuses et tropicales [Saint-Louis], Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), AP-HP - Hôpital Bichat - Claude Bernard [Paris], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), CHU Pitié-Salpêtrière [APHP]

المصدر: Lancet HIV
Lancet HIV, Elsevier, 2017, 4 (11), pp.e486-e494. ⟨10.1016/S2352-3018(17)30128-5⟩
LANCET HIV
The Lancet HIV, Vol. 4, No 11 (2017) pp. e486-e494

مصطلحات موضوعية: 0301 basic medicine, Male, PHARMACOKINETICS, Tenofovir/administration & dosage/adverse effects/pharmacokinetics/therapeutic use, Epidemiology, Coinfection/virology, DAILY DOLUTEGRAVIR, Administration, Oral, HIV Infections, Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use, law.invention, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, QUALITY-OF-LIFE, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Medicine and Health Sciences, Emtricitabine, 030212 general & internal medicine, CO-FORMULATED ELVITEGRAVIR, health care economics and organizations, ddc:616, Coinfection, Hepatitis C/virology, Viral Load, Hepatitis B, Hepatitis C, 3. Good health, Infectious Diseases, Administration, INITIAL TREATMENT, HIV-1/drug effects/physiology, RNA, Viral, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, medicine.symptom, medicine.drug, Oral, Adult, medicine.medical_specialty, Efavirenz, Nausea, Anti-HIV Agents, Immunology, Biological Availability, TREATMENT ADHERENCE, 03 medical and health sciences, EFAVIRENZ, Double-Blind Method, Virology, Internal medicine, Raltegravir Potassium, Raltegravir Potassium/administration & dosage/adverse effects/pharmacokinetics/therapeutic use, medicine, Humans, HIV Infections/drug therapy/virology, Adverse effect, Tenofovir, business.industry, ANTIRETROVIRAL-NAIVE ADULTS, Raltegravir, EFFICACY, 030112 virology, Viral Load/drug effects, Surgery, Discontinuation, Hepatitis B/virology, Emtricitabine/administration & dosage/adverse effects/pharmacokinetics/therapeutic use, Regimen, COMBINATION THERAPY, chemistry, Viral/blood/drug effects, HIV-1, Quality of Life, RNA, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b080de940b6244d90b7b170ca487b8b0
https://hal.archives-ouvertes.fr/hal-01745628

المؤلفون: Huldrych F. Günthard, Manuel Battegay, Enos Bernasconi, Stefan Erb, Alexandra Calmy, Pietro Vernazza, L Elzi, Hansjakob Furrer, Matthias Cavassini

المساهمون: Swiss HIV Cohort Study Group

المصدر: Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Günthard, Huldrych; Bernasconi, Enos; Battegay, Manuel (2017). Adverse events of raltegravir and dolutegravir. AIDS, 31(13), pp. 1853-1858. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001590 <http://dx.doi.org/10.1097/QAD.0000000000001590>
AIDS, vol. 31, no. 13, pp. 1853-1858
AIDS (London, England)
AIDS, Vol. 31, No 13 (2017) pp. 1853-1858

مصطلحات موضوعية: 0301 basic medicine, Male, HIV Infections, neuropsychiatric adverse events, Piperazines, Drug-Related Side Effects and Adverse Reactions/epidemiology, chemistry.chemical_compound, 0302 clinical medicine, Heterocyclic Compounds, 80 and over, Anti-HIV Agents/administration & dosage/adverse effects, Immunology and Allergy, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, ddc:616, Aged, 80 and over, Mental Disorders, Hazard ratio, Middle Aged, Mental Disorders/chemically induced/epidemiology, 3. Good health, dolutegravir, Infectious Diseases, Dolutegravir, Female, raltegravir, Heterocyclic Compounds, 3-Ring, Switzerland, medicine.drug, Cohort study, Adult, medicine.medical_specialty, Adolescent, Drug-Related Side Effects and Adverse Reactions, Anti-HIV Agents, Pyridones, 030106 microbiology, Immunology, HIV Infections/drug therapy, 610 Medicine & health, 03 medical and health sciences, Young Adult, Raltegravir Potassium/administration & dosage/adverse effects, Internal medicine, Raltegravir Potassium, Aged, Anti-HIV Agents/administration & dosage, Anti-HIV Agents/adverse effects, Heterocyclic Compounds, 3-Ring/administration & dosage, Heterocyclic Compounds, 3-Ring/adverse effects, Humans, Mental Disorders/chemically induced, Mental Disorders/epidemiology, Raltegravir Potassium/administration & dosage, Raltegravir Potassium/adverse effects, Withholding Treatment, Oxazines, medicine, Adverse effect, business.industry, HIV, toxicity, Raltegravir, Surgery, Discontinuation, Regimen, chemistry, Clinical Science: Concise Communications, 3-Ring/administration & dosage/adverse effects, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c07bb325d96b7974f6c2d69cf92e7e
https://boris.unibe.ch/104861/1/00002030-201708240-00010.pdf

المؤلفون: Kanters, Steve, Socias, Maria Eugenia, Paton, Nicholas I, Vitoria, Marco, Doherty, Meg, Ayers, Dieter, Popoff, Evan, Chan, Keith, Cooper, David A, Wiens, Matthew O, Calmy, Alexandra, Ford, Nathan, Nsanzimana, Sabin, Mills, Edward J

المصدر: ISSN: 2352-3018 ; The Lancet HIV, vol. 4, no. 10 (2017) p. e433-e441.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Acquired Immunodeficiency Syndrome/drug therapy, Adolescent, Adult, Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use, Female, HIV Infections/drug therapy, HIV Protease Inhibitors/administration & dosage/adverse effects/therapeutic use, HIV-1/drug effects, Humans, Lopinavir/administration & dosage/adverse effects/therapeutic use, Male, Network Meta-Analysis, Prospective Studies, Raltegravir Potassium/administration & dosage/adverse effects/therapeutic use, Retrospective Studies, Reverse Transcriptase Inhibitors/administration & dosage/adverse effects/therapeutic use, Ritonavir/administration & dosage/adverse effects/therapeutic use

Relation: info:eu-repo/semantics/altIdentifier/pmid/28784426; https://archive-ouverte.unige.ch/unige:112379; unige:112379

الاتاحة: https://archive-ouverte.unige.ch/unige:112379

المؤلفون: Wittkop, Linda, Arsandaux, Julie, Trevino, Ana, Schim van der Loeff, Maarten, Anderson, Jane, van Sighem, Ard, Böni, Jürg, Brun-Vezinet, Françoise, Soriano, Vicente, Boufassa, Faroudy, Brockmeyer, Norbert, Calmy, Alexandra, Dabis, François, Jarrin, Inma, Dorrucci, Maria, Duque, Vitor, Fätkenheuer, Gerd, Zangerle, Robert, Ferrer, Elena, Porter, Kholoud, Judd, Ali, Sipsas, Nikolaos V, Lambotte, Olivier, Shepherd, Leah, Leport, Catherine, Morrison, Charles, Mussini, Cristina, Obel, Niels, Ruelle, Jean, Schwarze-Zander, Carolyne, Sonnerborg, Anders, Teira, Ramon, Torti, Carlo, Valadas, Emilia, Colin, Celine, Friis-Møller, Nina, Costagliola, Dominique, Thiebaut, Rodolphe, Chene, Geneviève, Matheron, Sophie

المصدر: ISSN: 0305-7453 ; Journal of Antimicrobial Chemotherapy, vol. 72, no. 10 (2017) p. 2869-2878.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Adult, Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use, CD4 Lymphocyte Count, CD4-Positive T-Lymphocytes/immunology/virology, Cohort Studies, Europe, Female, HIV Infections/blood/drug therapy/immunology/virology, HIV-1/drug effects, HIV-2/drug effects, Humans, Internationality, Male, Middle Aged, RNA, Viral/blood, Viral Load

Relation: info:eu-repo/semantics/altIdentifier/pmid/29091198; https://archive-ouverte.unige.ch/unige:112382; unige:112382

الاتاحة: https://archive-ouverte.unige.ch/unige:112382

المؤلفون: Cahn, Pedro, Kaplan, Richard, Sax, Paul E, Squires, Kathleen, Molina, Jean-Michel, Avihingsanon, Anchalee, Ratanasuwan, Winai, Rojas, Evelyn, Rassool, Mohammed, Bloch, Mark, Vandekerckhove, Linos, Ruane, Peter, Yazdanpanah, Yazdan, Katlama, Christine, Xu, Xia, Rodgers, Anthony, East, Lilly, Wenning, Larissa, Rawlins, Sandy, Homony, Brenda, Sklar, Peter, Nguyen, Bach-Yen, Leavitt, Randi, Teppler, Hedy, Calmy, Alexandra

المصدر: ISSN: 2352-3018 ; The Lancet HIV, vol. 4, no. 11 (2017) p. e486-e494.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Administration, Oral, Adult, Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use, Biological Availability, Coinfection/virology, Double-Blind Method, Emtricitabine/administration & dosage/adverse effects/pharmacokinetics/therapeutic use, Female, HIV Infections/drug therapy/virology, HIV-1/drug effects/physiology, Hepatitis B/virology, Hepatitis C/virology, Humans, Male, Quality of Life, RNA, Viral/blood/drug effects, Raltegravir Potassium/administration & dosage/adverse effects/pharmacokinetics/therapeutic use, Tenofovir/administration & dosage/adverse effects/pharmacokinetics/therapeutic use, Viral Load/drug effects

Relation: info:eu-repo/semantics/altIdentifier/pmid/28918877; https://archive-ouverte.unige.ch/unige:112380; unige:112380

الاتاحة: https://archive-ouverte.unige.ch/unige:112380

المؤلفون: Alexandra Calmy, Frank de Wolf, Robert S. Hogg, Nathalie Vallier, Manuel Battegay, Viviane D. Lima, Bernard Hirschel, Julio S. G. Montaner, Joep M. A. Lange, Alain Nguyen, Ferdinand W. N. M. Wit, Peter Reiss, Benita Yip

المساهمون: Infectious diseases, Other departments, Amsterdam institute for Infection and Immunity, Amsterdam Public Health, Global Health

المصدر: Antiviral Therapy, Vol. 14, No 7 (2009) pp. 931-938
Antiviral therapy, 14(7), 931-938. International Medical Press Ltd

مصطلحات موضوعية: Adult, Male, Phosphonic Acids/therapeutic use, medicine.medical_specialty, Nevirapine, HIV Infections/ drug therapy, Anti-HIV Agents, Nevirapine/administration & dosage/adverse effects, Organophosphonates, HIV Infections, Drug Administration Schedule, Adenine/analogs & derivatives/therapeutic use, Cohort Studies, Drug Hypersensitivity, immune system diseases, Drug Hypersensitivity/etiology, Internal medicine, Anti-HIV Agents/administration & dosage/adverse effects, Humans, Medicine, ddc:576.5, Pharmacology (medical), Tenofovir, Retrospective Studies, Pharmacology, Reverse-transcriptase inhibitor, business.industry, Adenine, Hazard ratio, virus diseases, Odds ratio, Middle Aged, Discontinuation, Surgery, Regimen, Treatment Outcome, Infectious Diseases, HIV-1/drug effects, Cohort, HIV-1, Drug Therapy, Combination, Female, business, Cohort study, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a2f537254c8d4f63f02fa303da01c6
https://doi.org/10.3851/imp1418

المؤلفون: Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich

المصدر: Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, HIV Infections/ drug therapy/virology, Anti-HIV Agents, Antiretroviral Therapy, Highly Active/ adverse effects, HIV Infections, Pharmacology, Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use, law.invention, Nucleoside Reverse Transcriptase Inhibitor, Randomized controlled trial, law, Antiretroviral Therapy, Highly Active, Internal medicine, medicine, Humans, Pharmacology (medical), Protease inhibitor (pharmacology), RNA, Viral/blood, Prospective Studies, Saquinavir, ddc:616, Ritonavir, Intention-to-treat analysis, Reverse-transcriptase inhibitor, Reverse Transcriptase Inhibitors/administration & dosage/adverse, business.industry, virus diseases, Drug holiday, Thailand, CD4 Lymphocyte Count, Effects/ therapeutic use, Treatment Outcome, Infectious Diseases, HIV-1/drug effects, Ritonavir/administration & dosage/adverse effects/therapeutic use, HIV-1, RNA, Viral, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Female, Saquinavir/administration & dosage/adverse effects/therapeutic use, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becab3677e68c31cacbca2af440353cf
https://doi.org/10.1177/135965350501000604